Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients

Amelia Brunani, A. Caumo, S. Graci, G. Castagna, G. Viberti, A. Liuzzi

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients'. Together they form a unique fingerprint.

Medicine & Life Sciences